Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: Differential requirements for serum and CD14

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2674-2683

  Soler Rodriguez, Ana Maria ^a   Zhang, Hongwei ^b   Lichenstein, Henri S ^c   Qureshi, Nilofer ^d   Niesel, David W ^a   Crowe, Sheila E ^f   Peterson, Johnny W ^a   Kumpel, Gary R ^a,e  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CURAGEN CORPORATION   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; LIPOPROTEIN;

ARTICLE; BACTERIAL OUTER MEMBRANE; DOWN REGULATION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RHODOBACTER;

EID: 0034162578     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2674     Document Type: Article

References (78)

1. Guthrie, L. A., L. C. McPhail, P. M. Henson, and R. B. Johnston. 1984. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. J. Exp. Med. 160:1656.
2. Doerfler, M. E., R. L. Danner, J. H. Shelhamer, and J. E. Parrillo. 1989. Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene 84. J. Clin. Invest. 83:970.
3. Aida, Y., and M. J. Pabst. 1991. Neutrophil responses to lipopolysaccharide. Effect of adherence on triggering and priming of the respiratory burst. J. Immunol. 146:1271.
4. Nogare, A. R. D., and W. C. Yarbrough. 1990. A comparison of intact and deacylated lipopolysaccharide on human polymorphonuclear leukocytes. J. Immunol. 144:1404.
5. Marra, M. N., C. G. Wilde, J. E. Griffith, J. L. Snable, and R. W. Scott. 1990. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J. Immunol. 144:662.
6. Wright, S. D., and S. C. Silverstein. 1982. Tumor-promoting phorbol esters stimulate C3b and C3b′ receptor-mediated phagocytosis in cultured human monocytes. J. Exp. Med. 156:1149.
7. Kishimoto, T. K., M. A. Jutila, E. L. Berg, and E. C. Butcher. 1989. Neutrophil Mac-I and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245:1238.
8. Crockett-Torabi, E., B. Sulenbarger, C. Wayne Smith, and J. C. Fantone. 1995. Activation of human neutrophils through L-selectin and Mac-I molecules. J. Immunol. 154: 2291.
9. Kishimoto, T. K., and R. Rothlein. 1994. Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. Adv. Pharmacol. 25:117.
10. Mukaida, N., Y. Ishikawa, N. Ikeda, N. Fujioka, S. Watanabe, and K. Matsushima. 1996. Novel insight into the molecular mechanism of endotoxin shock: biochemical analysis of LPS receptor signaling in a cell free system targeting NF-κB and regulation of cytokine production/action through B2 integrin in vitro. J. Leukocyte Biol. 59:145.
11. Walcheck, B., J. Kahn, J. M. Fisher, B. B. Wang, R. S. Fisk, D. G. Payan, C. Feeban, R. Betageri, K. Darlak, A. F. Spatola, and T. K. Kishimoto. 1996. Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 380:720.
12. Boffegaard, N., L. Kjeldsen, H. Sengelov, M. S. Diamond, T. A. Springer, H. Clarke Anderson, T. K. Kishimoto, and D. F. Bainton. 1994. Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-I in human neutrophils during stimulation with inflammatory mediators. J. Leukocyte Biol. 56:80.
13. Bennett, T. A., E. B. Lynam, L. A. Sklar, and J. S. Rogel. 1996. Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecules from leukocytes: functional consequences for neutrophil aggregation. J. Immunol. 156:3093.
14. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanism of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437.
15. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
16. Haziot, A., B.-Z. Tsuberi, and S. M. Goyert. 1993. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor α in response to lipopolysaccharide. J. Immunol. 150:5556.
17. Antalszalmas, P., J. A. G. Vanstrijp, A. J. L. Weersink, J. Verhoef, and K. P. M. Van Kessel. 1997. Quantitation of surface CD14 on human monocytes and neutrophils. J. Leukocyte Biol. 61:721.
18. Bordessoule, D., M. Jones, K. C. Gatter, and D. Y. Mason. 1993. Immunological patterns of myeloid antigens: CD13, CD14, CD16, CD31, CD65, and CD67. Br. J. Haematol. 83:370.
19. Su, G. L., R. L. Simmons, and S. C. Wang. 1995. Lipopolysaccharide binding protein participation in cellular activation by LPS. Crit. Rev. Immunol. 15:201.
20. Hailman, Z., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L A. Busse, M. M. Zukowsli, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269.
21. Hailman, E., J. J. Albers, G. Wolfbauers, A.-Y. Tu, and S. D. Wright. 1996. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J. Biol. Chem. 271:12172.
22. Tobias, P. S., J. C. Mathison, and R. J. Ulevitch. 1988. A family of lipopolysaccharide binding proteins involved in responses to Gram-negative sepsis. J. Biol. Chem. 261:11479.
23. Haziot, A., S. Chen, E. Ferrero, M. O. Low, R. Silbert, and S. N. Goyert. 1988. The monocyte differentiation antigen CD14 is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141:547.
24. Kitchens, R. L., and R. S. Munford. 1995. Enzymatically deacylated LPS can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270:9904.
25. Kitchens, R. L., R. J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake be CD 14 mediated pathway. J. Exp. Med. 176:485.
26. Perera, P. Y., S. N. Vogel, G. R. Detore, A. Haziot, and S. M. Goyert. 1997. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with LPS or Taxol. J. Immunol. 158:4422.
27. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.
28. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Toll-like receptor-4 (TLR4)-deficient mice are hyporesponsive to LPS: evidence for TLR4 as the LPS gene product. J. Immunol. 162:3749.
29. Kirschning, C. J., H. Wesche, T. M. Ayres, and M. Rothe. 1998. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2091.
30. Yang, R.-B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goodard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 395:284.
31. Heine, H., C. J. Kirschning, E. Lien, B. G. Monks, M. Rothe, and D. T. Golenbock. 1999. Cutting edge: cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J. Immunol. 162:6971.
32. Vogel, S. N., D. Johnson, P. Y. Perera, A. Medvedev, L. Lariviere, S. T. Qureshi, and D. Malo. 1999. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack a dominant negative mutation. J. Immunol. 162:5666.
33. DiRienzo, J. M., K. Nakamura, and M. Inouye. 1978. The outer membrane proteins of Gram-negative bacteria: biosynthesis, assembly, and functions. Annu. Rev. Biochem. 47:481.
34. Melchers, F., V. Braun, and C. Galanos. 1975. The lipoprotein of the outer membrane of E. coli: a B lymphocyte mitogen. J. Exp. Med. 142:473.
35. Biesert, L., W. Scheuer, and W. G. Bessler. 1987. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes: isolation and characterization of binding proteins. Eur. J. Biochem. 162:651.
36. Besslet, W., and B. Ottenbreitt. 1977. Studies of lipoprotein from the outer membrane of E. coli. Biochem. Biophys. Res. Commun. 75:239.
37. Hauschildt, S., P. Hoffmann, H. U. Beuscher, G. Duffiues, P. Heinrick, K. H. Weismuller, C. Jung, and W. G. Besster, 1990. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur. J. Immunol. 20:63.
38. Hoffman, P., S. Heinle, U. F. Schade, H. Loppnow, A. J. Ulmer, H. D. Flad, G. Jung, and W. G. Bessler. 1988. Stimulation of human and mouse adherent cells by bacterial lipoprotein and synthetic lipoprotein analogues. Immunobiology 177:158.
39. Zhang, H., L. Kaur, D. W. Niesel, G. S. Seethaaramaiah, J. W. Peterson, B. S. Prabhakar, and G. R. Kumpel. 1997. Lipoprotein from Yersinia enterocolitica contains epitopes that cross-react with the human thyrotropin receptor. J. Immunol. 158:1976.
40. Zhang, H., L. Kaur, D. W. Niesel, G. S. Seetharamaiah, J. W. Peterson, L. B. Justement, B. S. Prabhakar, and G. R. Klimpel. 1996. Yersinia enterocolitica envelope proteins that are cross-reactive with the thyrotropin receptor (TSHR) also have B-cell mitogenic activity. J. Autoimmun. 9:509.
41. Zhang, H., J. W. Peterson, D. W. Niesel, and G. R. Klimpel. 1997. Bacterial lipoprotein and LPS not synergistically to induce lethal shock and proinflammatory cytokine production. J. Immunol. 159:4868.
42. Zhang, H., D. W. Niesel, J. W. Peterson, and G. R. Klimpel. 1998. Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect. Immun. 66: 5196.
43. Fearon, D. T., and L. A. Collins. 1983. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J. Immunol. 130:370.
44. Jarvis, B. W., and N. Qureshi. 1997. Inhibition of LPS-induced transcription factor Sp1 binding by spectrally pure diphosphoryl lipid A from Rhodobacter sphaeroides, protein kinase inhibitor H-8, and dexamethasone. Infect. Immun. 65:1640.
45. Lynn, W. A., C. R. H. Raetz, N. Qureshi, and D. T. Golenbock. 1991. LPS-induced stimulation of CD11b/CD18 expression on neutrophils: evidence of specific receptor-based response and inhibition by lipid A-based antagonists. J. Immunol. 147:3072.
46. Juan, T. S. C., E. Hailman, M. J. Kelley, S. D. Wright, and H. S. Lichenstein. 1995. Identification of a domain in soluble CD14 essential for LPS signaling but not LPS binding. J. Biol. Chem. 270:17237.
47. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of LPS and LPS binding protein. Science 249: 1431.
48. Lynn, W. A., and D. T. Golenbock. 1992. Lipopolysaccharide antagonists. Immunol. Today 13:271.
49. Manthey, C. L., P. Y. Perera, N. Qureshi, P. L. Stutz, T. A. Hamilton, and S. N. Vogel. 1993. Modulation of LPS-induced macrophage gene expression by Rhodobacter sphaeroides lipid A and SDZ 880.431. Infect. Immun. 61: 3518.
50. Morrison, T. B., J. H. Weis, and J. J. Weis. 1997. Borrelia burgdorferi outer protein A (OspA) activates and primes human neutrophils. J. Immunol. 158:4838.
51. Gaimbartolomel, G. H., V. A. Dennis, B. L. Lasater, and M. T. Philipp. 1999. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect. Immun. 67:140.
52. Sellati, T. J., D. A. Douis, R. L. Kitchens, R. P. Darveau, J. Pugin, R. J. Ulevitch, S. C. Gangloff, S. M. Goyert, M. V. Norgard, and J. D. Radolf. 1998. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD-14 dependent pathway distinct from that used by lipopolysaccharide. J. Immunol 160:5455.
53. Wooten, R. M., T. B. Morrison, J. H. Weis, S. D. Wright, R. Thieringer, and J. J. Weis. 1998. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol. 160:5485.
54. Radolf, J. D., M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson, and B. Beutler. 1991. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis: analysis using a CAT reporter construct. J. Immunol. 147:1968.
55. Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell, mitogenic, and cytokine-stimulatory properties. Infect. Immun. 61:3843.
56. Norgard, M. V., L. L. Arndt, D. R. Akins, L. L. Curetty, D. A. Harrich, and J. D. Radolf. 1996. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-κB. Infect. Immun. 64:3845.
57. Weis, J. J., Y. Ma, and L. F. Erdile. 1994. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect. Immun. 62:4632.
58. Seiler, K. P., and J. J. Weis. 1996. Immunity to Lyme disease: protection, pathology and persistence. Curr. Opin. Immunol. 8:503.
59. Sellati, T. J., L. D. Abrescia, J. D. Radolf, and M. B. Furie. 1996. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect. Immun. 64:3180.
60. Wooten, R. M., V. R. Modur, T. M. McIntyre, and J. J. Weis. 1996. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-κB and inflammatory activation in human endothelial cells. J. Immunol. 157:4584.
61. Melchers, F., V. Braun, and C. Galanos. 1975. The lipoprotein of the outer membrane of E. coli: a B lymphocyte mitogen. J. Exp. Med. 142:473.
62. Biesert, L., W. Scheuer, and W. G. Bessler. 1987. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes: isolation and characterization of binding proteins. Eur. J. Biochem. 162:651.
63. Hauschildt, S., P. Hoffman, H. U. Beuscher, G. Dufhus, P. Heinrich, K. H. Weismuller, G. Jung, and W. G. Bessler. 1990. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide cytokine production phagocytosis and Ia expression. Eur. J. Immunol. 20:63.
64. Bessler, W. G., and B. P. Ottenbrit. 1977. Studies on the mitogenic principle of lipoprotein from the outer membrane of E. coli. Biochem. Biophys. Res. Commun. 76:239.
65. Bessler, W. G., K. Resch, E. Hancock, and K. Hantke. 1997. Induction of lymphocyte-proliferation and membrane changes by lipoprotein derivatives of the lipoprotein from the outer membrane of E. coli. Z. Immunitaetsforsch. 153:11.
66. Bessler, W. G., M. Cox, A. Lex, B. Suhs, K. H. Wiesmuller, and C. Jung. 1985. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J. Immunol. 135:1900.
67. Hauschildt, S., P. Hoffman, H. U. Beuscher, G. Dufhues, P. Henrick, K. H. Wiesmuller, C. Jung, and W. G. Bessler. 1990. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Ear. J. Immunol. 20:63.
68. Hoffman, P., S. Heinle, U. F. Schade, H. Loppnow, A. J. Ulmer, H. D. Flad, G. Jung, and W. G. Bessler. 1988. Stimulation of human and mouse adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology 177:158.
69. Radolf, J. D., L. L. Arndt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2866.
70. Akins, D. R., B. K. Purcell, M. Mitra, M. V. Norgard, and J. D. Radolf. 1993. Lipid modification of the 17-kilodalton membrane immunogen of Treponema pallidum determines macrophage activation as well as amphiphilicity. Infect. Immun. 61:1202.
71. Cleveland, M. G., J. D. Gorham, T. L. Murphy, E. Tuomanen, and K. M. Murphy. 1996. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64:1906.
72. Gupta, D., T. N. Kirkland, S. Viriyakosol, and R. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271:23310.
73. Kusunoki, T. E. Hailman, T. S. C. Juan, H. S. Lichenstein, and S. D. Wright. 1995. Molecules form Siaphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med. 182:1673.
74. Wright, S. D. 1995. CD14 and innate recognition of bacteria. J. Immunol. 155:6.
75. Ulevilch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanism of cell stimulation by bacterial endotoxin. Anna. Rev. Immunol. 13:437.
76. Kitchens, R. L., and R. S. Munford. 1995. Enzymatically deacylated LPS can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270:9904.
77. Kitchens, R. L., R. J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in human macrophage cell line without inhibiting LPS uptake by CD14 mediated pathway. J. Exp. Med. 176: 485.
78. Golenbock, D. T., R. Y. Hampton, N. Qureshi, K. Takayama, and C. R. H. Raetz. 1991. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266:19490.